Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Affymetrix, Albany, Alkeran, allergic, AMAG, Amphastar, Anderson, anemia, array, arrest, ASCT, AstraZeneca, ATM, Ayeni, baby, belonging, Bendeka, Betadex, bioequivalence, blockage, bowel, breakdown, breath, bundle, cardiopulmonary, CHOP, chromosome, Codification, commensurate, complication, concept, Congressional, constipation, CR, creatinine, CRi, CRO, cyber, declaratory, dehydration, deliverable, deploy, dermatologic, distraction, docetaxel, dyspnea, eleven, Enanta, engraftment, espionage, Ether, executory, Exon, extravasation, fatigue, FBR, febrile, feet, fever, gastrointestinal, Genomic, Glen, Hartsock, Harvard, hematochezia, hepatic, hepatotoxicity, hundred, hypersensitivity, implied, infection, infertility, Infinity, inflationary, intraperiod, IRC, IRS, Istodax, IWC, kidney, leakage, malware, manifested, MD, median, membrane, Merrimack, mg, MiMedx, MLV, mouth, myeloablation, myelodysplastic, nausea, nerve, Neulasta, neurologic, neuropathy, neutrophil, obstruction, Olutayo, overstock, Pacific, pancytopenia, Pernix, persuasive, platelet, pneumonia, pose, potent, privacy, prolonged, push, pyrexia, QAPZOLA, reaction, reclassified, remission, remitted, reoccur, respiratory, retrospective, retrospectively, Sanofi, sensitive, Sodium, square, standalone, stomach, store, stream, subtype, Sulfobutyl, Supplementary, suppression, syndrome, TC, theft, throat, thrombocytopenia, tissue, transmit, transparency, Trump, Twenty, unborn, unclear, unconfirmed, unearned, University, unrealizable, unresolved, unspecified, unwound, Vanda, vigorously, vomiting, Wainwright, weekly, Workshop, xiv
Removed:
abandonment, accessibility, acetylation, alisertib, announcement, arrive, Astra, BioMarin, bore, cancellation, chromatin, collaborating, concentration, consulting, CTCL, cytotoxic, declined, distinct, enable, enjoin, eoquin, explored, exploring, Fargo, FIFO, flower, GCSF, gene, generation, Genta, Handok, importantly, injunctive, Innopharma, Interbank, intracellular, involuntary, joined, lender, LIBOR, London, lowest, margin, misleadingly, Mylan, optimistic, predominant, preference, putative, ratio, region, renazorb, repaid, repeated, resistance, responding, retention, retired, revolving, RFC, safely, STAR, strong, subpoena, sustainable, transcription, travel, Treanda, Turning, unamortized, unconverted, winding, Zeneca
Filing tables
Filing exhibits
Related press release
SPPI similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-37585, 333-52331, 333-73009, 333-92855, 333-37180, 333-38710, 333-42852, 333-51388, 333-60966, 333-64432, 333-64444, 333-102587, 333-105814, 333-108658, 333-110103, 333-115759, 333-121612, 333-125208, 333-135029, 333-142628, 333-150260, 333-190413, 333-194823, and 333-208760 on Form S‑3, and Registration Statement Nos. 333-30345, 333-54246, 333-106427, 333-119833, 333-134566, 333-160312, 333-160705, 333-164014, 333-176681, and 333-202761 on Form S‑8 of our reports dated March 14, 2017, relating to the consolidated financial statements and financial statement schedule of Spectrum Pharmaceuticals, Inc., and the effectiveness of Spectrum Pharmaceutical Inc.’s internal control over financial reporting, appearing in this Annual Report on Form 10‑K of Spectrum Pharmaceuticals, Inc. for the year ended December 31, 2016.
/s/ Deloitte & Touche LLP
Costa Mesa, California
March 14, 2017